Abstract:Objective To evaluate the differences in three kinds of meibomian phospholipid composition in healthy subjects and in patients suffering from meibomian gland dysfunction (MGD).Methods In this prospective study, 22 MGD patients (MGD group) and 30 age and sex matched heahhy individuals (control group) were enrolled.One eye of each subject was included in the study.MGD patients underwent sequential examinations as follows: the property of meibomian secretion, tear film break-up time (BUT), corneal fluorescein staining (CFS), Schirmer Ⅰ test and lid margin and ocular surface examinations by slit lamp.Meibomian gland secretions were collected using sterile stainless steel curettes in the healthy control group and MGD group after gentle massage of the lid margin with sterile cotton swabs.The meibomian phospholipids, mainly lysophosphatidylcholine,phosphatidylethanolamine, and sphingomyelin, were detected using liquid chromatography/tandem mass spectrometry (LC-MS/MS), and comparisons were made between the MGD group and the healthy control group.The data from the two groups were compared by an independent-samples t test and a Pearson correlation analysis was used to assess the correlation between the relative composition concentrations of the three kinds of phospholipids with the clinical parameters of the objective signs of MGD.Results The relative concentration level of lysophosphatidylcholine in the MGD group was significantly higher than that in the healthy controls (t=-2.45, P＜0.05), while phosphatidylethanolamine and sphingomyelin levels were lower in the MGD group than in healthy controls (t=16.73, P＜0.01 and t=18.59, P＜0.01, respectively).The relative concentration of lysophosphatidylcholine was positively correlated with the property of meibomian secretion, CFS, lid margin and ocular surface examination by slit lamp (r=0.602, 0.716, 0.710, P＜0.01, respectively);while a negative correlation was found with the BUT and Schirmer Ⅰ test (-0.628,-0.477, P＜0.05, respectively).The relative concentrations of phosphatidylethanolamine and sphingomyelin were negatively correlated with the properties of the meibomian secretion, CFS, lid margin and ocular surface examination (r=-0.565,-0.724,-0.702;r=-0.597,-0.719,-0.698, P＜0.01, respectively).However, a positive correlation was detected with the BUT and Schirmer Ⅰ test (r=0.659, 0.498, P＜0.05;r=0.631, 0.468, P＜0.05, respectively).Conclusion The profile of the three kinds of meibomian phospholipids (lysophosphatidylcholine, phosphatidylethanolamine and sphingomyelin) in MGD patients is dramatically different from healthy subjects.Its significant correlation with the clinical parameters of the signs of meibomian gland dysfunction suggest that a change in phospholipids composition in meibomian gland secretions is a probable reason for the development of MGD.

Evaluation of the special ocular surface characteristics in Asian blepharokeratoconjunctivitis related Meibomian gland dysfunction patients

Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients with Primary Sjogren's Syndrome

Incomplete Blinking May Attribute to the Development of Meibomian Gland Dysfunction.

Therapeutic Effect of Intense Pulsed Light with Optimal Pulse Technology on Meibomian Gland Dysfunction with and Without Ocular Demodex Infestation

The treatment effectiveness of local application of glucocorticoid for meibomian gland dysfunction related dry eye

Clinical Results of Intraductal Meibomian Gland Probing Combined with Intense Pulsed Light in Treating Patients with Refractory Obstructive Meibomian Gland Dysfunction: a Randomized Controlled Trial

The impact of keratoconjunctivitis associated with meibomian gland dysfunction

Evaluation of Optical Coherence Tomography Meibography in Patients With Obstructive Meibomian Gland Dysfunction

Identification of Meibomian Phospholipids in Meibomian Gland Dysfunction Patients Using Liquid Chromatography/tandem Mass Spectrometry

Morphological Evalution of Obstructive Meibomian Gland Dysfunction by Noninvasive Keratograph

Evaluation of visual quality in patients with meibomian gland dysfunction

Improving the understanding for meibomian gland dysfunction Paying attention to the management of meibomian gland dysfunction associated-dry eye

Risk Factors for Meibomian Gland Disease Assessed by Meibography

Correlation Study Between Abnormal Morphology of Meibomian Glands and Meibum in Patients With Dry Eye Disease Under in vivo Confocal Microscopy

A Clinical Study on the Role of the Meibomian Gland in Conjunctivochalasis

The lack of correlation between symptoms and signs in patients with meibomian gland dysfunction: a secondary analysis of the multicenter, randomized controlled trial

A Novel Noninvasive Ocular Surface Analyzer for the Assessment of Dry Eye with Meibomian Gland Dysfunction.

[Changes in human meibum with meibomian gland dysfunction].

A Retrospective Study of Treatment Outcomes and Prognostic Factors of Intense Pulsed Light Therapy Combined With Meibomian Gland Expression in Patients With Meibomian Gland Dysfunction

Pathogens in the Meibomian Gland and Conjunctival Sac: Microbiome of Normal Subjects and Patients with Meibomian Gland Dysfunction.

Is Meibomian Gland Dysfunction One Disease? Heterogeneity Among Phenotypes